Human carcinomas are comprised of complex mixtures of tumor cells that are known to compete indirectly for nutrients and growth factors. Whether tumor cells could also compete directly, for example by elimination of rivals, is not known. Here we show that human cells can directly compete by a mechanism of engulfment called entosis. By entosis, cells are engulfed, or cannibalized while alive, and subsequently undergo cell death. We find that the identity of engulfing ("winner") and engulfed ("loser") cells is dictated by mechanical deformability controlled by RhoA and actomyosin, where tumor cells with high deformability preferentially engulf and outcompete neighboring cells with low deformability in heterogeneous populations. We further find that activated Kras and Rac signaling impart winner status to cells by downregulating contractile myosin, allowing for the internalization of neighboring cells that eventually undergo cell death. Finally, we compute the energy landscape of cell-in-cell formation, demonstrating that a mechanical differential between winner and loser cells is required for entosis to proceed. These data define a mechanism of competition in mammalian cells that occurs in human tumors.
Introduction
The cell number of each tissue in metazoan organisms is carefully controlled as disruptions in cell number homeostasis can lead to pathologies associated with inappropriate cell loss (e.g., tissue degeneration) or cell gain (e.g., tumor growth). Programs that limit clonal expansion within tissues, such as cell death or senescence, can be executed cell-autonomously, but evidence has emerged that individual cells within a tissue can also eliminate neighboring cells threatening tissue integrity by inducing cell death non-cell-autonomously. Examples of such "competition" between individual cells, where "fit" cells eliminate neighboring "less-fit" cells, have emerged from genetic studies in Drosophila melanogaster. In this system, wild-type cells, for example, outcompete less-fit cells harboring mono-allelic deletion of ribosomal protein genes ("Minute" cells) by inducing their death [1, 2] . Similarly, cells overexpressing the dmyc oncogene, socalled "super-competitors", overpopulate at the expense of wild-type cells that are eliminated [3, 4] . In each case, the total cell number, or overall tissue size, is maintained at the expense of "loser" cells that are killed by "winners", through a program termed "cell competition".
It has been argued that cell competition in Drosophila requires cell engulfment to induce the death of "loser" cells. For example, competition between wild-type and Minute cells requires engulfment at the borders of rival clones, mediated by the small GTPase Rac-1, to promote both the death and clearance of loser cells, suggesting that engulfment plays a direct role in allowing winner cells to kill losers [5] . Similarly, clones of cells with mu-tations in the tumor suppressor genes scrib and dlg have been shown to be engulfed and eliminated by neighboring wild-type cells [6] , suggesting that cell competition can be mediated in some contexts by engulfment-induced cell death that follows direct contact between winners and losers.
The identification of cell competition in Drosophila has led to the speculation that similar modes of competition between mammalian cells could occur in human tumors [7, 8] . The observation that mammalian cells expressing activated Src or Kras are extruded when surrounded by normal cells in monolayer cultures has demonstrated one mode of competitive interactions between neighboring mammalian cells, which could influence tumorigenesis [9, 10] . Similarly, knockdown of the polarity protein Scribble and the Lgl-binding protein Mahjong, whose loss induces cell competition in Drosophila, leads to death of mammalian cells only when knockdown cells are mixed with wild-type cells in culture [11, 12] . While cell engulfment is argued to control cell competition in Drosophila, no examples of competition between mammalian cells where engulfment could contribute to the killing of loser cells by winners have been identified.
Recently, a mechanism of mammalian cell death called entosis was reported, which is induced by cell engulfment [13] . The cannibalistic cell-in-cell structures formed by this mechanism are found in a variety of human tumors [13] [14] [15] , and roles for this process in both tumor suppression and promotion have been proposed [15] [16] [17] . Although entotic cells are engulfed while alive, the majority undergo cell death, and are in fact killed by the neighboring cells into which they are engulfed [17] . We thus hypothesized that this mechanism of cell cannibalism could allow neighboring tumor cells to undergo a form of competition, as "winner" cells could ingest and kill neighboring "loser" cells. Here we investigate cell properties and signaling mechanisms that define winner and loser cell status during entosis, and examine whether entosis can mediate cell competition between tumor cells.
Results

Entosis mediates competition between human cells
As shown in a companion paper by Sun et al. [18] , sibling tumor cells can undergo entosis in suspension cultures, a process associated with the accumulation of actomyosin in only one cell of a pair, demonstrating that "winner" and "loser" cell status can be dictated by transient differences between isogenic cells. However, we wondered whether genetic differences between cells in heterogeneous populations could contribute to the determination of winner and loser status, and in this manner entosis could mediate competition. Interestingly, non-tumorigenic MCF10A mammary epithelial cells were nearly always engulfed, becoming losers, when they were mixed with breast tumor cells expressing endogenous (MCF7) or exogenous (MDA-MB-231-E-cadherin) E-cadherin ( Figure 1A) . Similarly, non-tumorigenic pancreatic cells (HPDE) were losers when mixed with pancreatic tumor cells (PancTu; Figure 1A ). In general, tumor cells were winners over non-tumor cells even when mixed with cells of different cell types ( Figure 1A ). We noted that tumor cells used in our cell mixing assays had lower levels of total phosphorylated myosin light chain 2 (pMLC2) than both non-tumor cell lines, suggesting that a low setpoint of contractile myosin might correlate with winner status. Figure S1C ). Remarkably, the preferential engulfment of loser cells by winners and the induction of loser cell death were recapitulated in mixed xenograft tumors in vivo ( Figure 1C-1E and Supplementary information, Figures S1D, S1E and S2). In this context, engulfment and entotic cell death were suppressed by treatment of mice with the ROCK inhibitor Y27632, consistent with the engulfment program entosis ( Figure 1C and 1E) .
To examine whether cell engulfment can promote competition between tumor cell populations, we designed a cell competition assay where we could carefully quantify entosis, as well as proliferation and other forms of cell death, in mixed cultures treated with or without the ROCK inhibitor Y27632. The repetitive induction of entosis by cycles of suspension and adherence led to the progressive decrease in number of losers (MCF7, labeled with GFP), and increase in that of winners (VmCUB3, labeled with mCherry), as quantified by fluorescence microscopy ( Figure 2A and 2B) and western blotting ( Figure 2C ). This competition between tumor cells could be inhibited by Y27632 treatment, which blocks entosis ( Figure 2 ). Importantly, Y27632 did not increase proliferation of loser cells, but rather slightly decreased it (Supplementary information, Figure S3A ), and also had no significant effect on other forms of cell death measured by the incorporation of the nuclear dye DAPI into dead cells (Supplementary information, Figure S3B ). These data suggest that entosis mediates a form of competition between human tumor cell populations.
Winner cell status correlates with increased mechanical deformability
We next attempted to investigate cell properties that may dictate winner versus loser status during entosis. We hypothesized that the accumulation of actomyosin at the cortex of loser cells, as shown in the companion paper by Sun et al. [18] , would drive changes in cortical mechanics between daughter cells, which could dictate winner and loser cell status. Indeed, in MCF10A cultures loser (inner) cells were 45% ± 8% less deformable than winner (outer) cells when interrogated by micropipette aspiration (MPA; Figure 3A and Table 1 ), demonstrating differential mechanical deformability between winners and losers, which is consistent with the loser-specific accumulation of actomyosin. Similarly, a recently published study also observed that loser cells exhibited greater rigidity than winner cells [19] . Overexpression of RhoA, ROCKI, or ROCKII was sufficient to confer loser status to cells mixed with normal cells, whereas inhibition of RhoA by overexpression of RhoA-N19 (dominant-negative mutant of RhoA) or the Rho-GTPase activating protein (GAP) p190A, showed the opposite effect ( Figure 3B ). These data suggest that the accumulation of actomyosin is ROCK-dependent (see a companion paper by Sun et al. [18] ) and is sufficient to promote the uptake of losers. Notably, VmCUB3 tumor cells, which were found to be winners over MCF7, were almost two-fold more deformable than MCF7 cells ( Figure 3C and Table  1) , consistent with the model where mechanical deformability, a property controlled by Rho-ROCK signaling and actomyosin, dictates the identity of winner and loser cells during entosis.
Actomyosin contractility is a critical driving force of entosis
To further examine the observed differences in actomyosin between winner and loser cells, we used math- Figure 4B ) symmetry breaking (depending on the relative timing of the initiation of internalization between pairs of cells forming adhesions), indicate that myosin II functions to greatly reduces ∆E total to negative values (i.e., ∆E total < 0), allowing entosis to proceed spontaneously. Actomyosin contractility within internalizing cells is therefore a critical driving force of entosis that is likely sufficient to promote cell shape changes associated with engulfment.
Oncogenic Kras imparts winner status to cells
To identify potential genetic determinants of winner status in tumor cells, we considered whether known pathways activated in tumor cells could modulate contractile myosin and influence entosis. Whereas non-tumorigenic cells were losers when paired with all tumor cell lines tested, we noted that MCF7 cells were losers when paired with cells with active mutant Kras (231/E and PancTu, Figure 5A ). Expression of active mutant KrasV12 was sufficient to impart winner status to non-tumorigenic cells ( Figure 5B), coincident with decreased pMLC2 levels ( Figure 5C and Supplementary information, Figure S5A) , suggesting that Kras activation may influence entosis by inhibiting actomyosin contraction. Indeed, expression of KrasV12 also increased the mechanical deformability of non-tumorigenic cells ( Figure 5D and Table 1 ). Similarly, knockout of a mutant Kras allele in colon tumor cells increased pMLC2 levels ( Figure 5E ), as previously reported [20] , and converted these mutant Kras-knockout cells into losers over their tumorigenic counterparts ( Figure 5F ). Together, these data demonstrate that the activation of Kras influences entosis by inducing winner status. Rac1 is required for KrasV12-induced winner status As Ras signaling is known to induce Rac1 activation, we examined the effect of Rac1 activation on entosis. Rac1 was required for winner status induced by KrasV12 in non-transformed cells, as shRNA-mediated knockdown of Rac1 partially reverted KrasV12-induced phenotype ( Figure 6A ). Like KrasV12, constitutive-active Rac1(V12) decreased pMLC2 levels ( Figure 6E and Supplementary information, Figure S5B ) and conferred winner status to cells ( Figure 6B ). Conversely, dominant-negative Rac1N17-expressing cells were shifted toward loser status ( Figure 6B) . Similarly, the majority of Rac1-knockdown cells, which exhibited increased levels of pMLC2, became losers in a ROCKI/II-dependent manner ( Figure 6C , 6D and Supplementary information, Figure S5C-S5D) .
Altogether, these data fit a model where the setpoint of contractile myosin dictates engulfed cell identity during entosis. Activated Ras/Rac signaling downregulates ROCK/Rho activity and actomyosin contractility, promoting competitive cell engulfment (Supplementary information, Figure S6 ).
Discussion
In this study, we reveal a mode of cell competition occurring between human cells, which involves cell engulfment and killing. Competition by entosis, a mechanism of cell cannibalism, mediates the killing of "loser" cells by "winners" in mixed cell populations. We find that differences in mechanical deformability between epithelial cadherin-expressing cells determine which cells "win" in this program of competitive engulfment. It has been reported previously that tumor progression is associated with decreased cortical tension or increased mechanical deformability of tumor cells [21] [22] [23] , a property that may facilitate metastasis by promoting cell invasion away from primary tumors [24] . We find that expression of constitutively active Kras mutant leads to activation of Rac1, which subsequently increases mechanical deformability in epithelial cells, similar to previous observations in fibroblasts [25] . While Rac1 is required for Kras to induce winner status, we cannot rule out the possibility that other pathways engaged by Kras activation, such as MAP kinase signaling, PI-3-kinase, or even autophagy, could also participate in regulating entosis. Our data also demonstrate that highly deformable tumor cells ingest neighboring tumor cells that are less deformable, which could contribute to selection for oncogenic insults that increase cell deformability within heterogeneous tumor cell populations. Human tumors are known to be mechanically heterogeneous [26] , which may also prime tumor cell populations for entosis.
As discussed in the companion paper by Sun et al. [18] , cytoskeletal tension associated with entosis involves RhoA activity and contractile myosin that are positioned in patterns resembling those previously reported between pairs of adherent cells forming cell-cell junctions [27] , suggesting that entosis results from imbalances of otherwise normal cell-cell adhesion-associated forces. The force imbalance alone could be sufficient to further activate myosin II contractility and promote entosis [28, 29] . The activation of RhoA in one cell of a pair, or introduction of phosphomimetic MLC, has been shown to induce growth of adherens junction as a result of increased tugging force by actomyosin [30] . Here, we show a similar effect of tension imbalance that promotes junctional growth that is sufficient to enwrap an entire cell. It is conceivable that such imbalances in cell deformability may occur normally between adherent cells, but the counterbalancing effect of cell-matrix adhesion blocks cell engulfment, as proposed previously [13] .
Our previous reports [13, 17] and data presented in the companion paper by Sun et al. [18] demonstrate that entosis may suppress transformed growth by inducing cell death; however, entosis could also promote tumor progression by inducing ploidy changes [16] and supplying engulfing cells with nutrients [31] . Human tumors are known to be genetically heterogeneous, as many are composed of multiple independent clones with genetic alterations such as changes in ploidy [32] . Entosis could allow neighboring cells to compete by acting as a mechanism of cell death of losers, while endowing winners with ploidy changes that promote tumorigenesis. Indeed, we and others have shown that "cell-in-cell" structures in human tumors, which resemble those formed by entosis, occur most frequently in high-grade, aggressive breast tumors that are known to exhibit high rates of aneuploidy [16, 33] . While the mechanisms underlying the formation of such "cell-in-cell" structures in human tumors remain controversial [14] , we show here that the engulfment and killing of loser cells by winners, which is dependent on epithelial cadherin expression and ROCK activity in culture, also occurs between tumor cells in xenografts. Further, this cell cannibalism is reduced by treating mice with the ROCK inhibitor Y27632, providing evidence that entosis indeed promotes cell-in-cell formation in vivo.
Like cell competition defined in Drosophila, engulfment by entosis allows cells to outcompete neighbors of different genotypes. However, this entotic mechanism has several notable distinctions. First, cell death by entosis is generally non-apoptotic, whereas losing clones in Drosophila die by apoptosis [34] . Second, we observe that neighboring cell engulfment mediates competition between human cells. This observation is in contrast to a recent report which suggests that in Drosophila tissues, the post-apoptotic engulfment of loser cells may be mediated by hemocytes, which phagocytize cell corpses, rather than by the neighboring cells [35] . While the identity of the engulfing cells and whether engulfment itself mediates competition in Drosophila are controversial, we clearly show that neighboring cell-mediated engulfment and killing occur in mixed populations of human cells. Other mechanisms of competition between mammalian cells have been demonstrated, including the differential extrusion of cells of mixed genotypes from monolayer cultures [9, 10] , competition between cells of the early embryo [36] [37] [38] , and competition between hematopoietic progenitors driven by differences in p53 activity [39, 40] . Perhaps diverse competition mechanisms reflect a stringent requirement for homeostasis in different contexts within various tissue types of metazoan organisms during development and adulthood. To our knowledge, our data are the first to demonstrate a mechanism of direct competition between mammalian cells, which utilizes cell engulfment that is dependent on cell adhesion and differential cell mechanics to allow winners to kill losers.
Materials and Methods
Cells and culture conditions
MCF7, MCAS, PancTu, VmCUB3, 575A, HCT116, HKe-3 [41] , DLD1, DKs-8, and 293FT cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS, Sigma-Aldrich). MDA-MB-231, MDA-MB-453 and their derivative cell lines were maintained in Leibovitz's L-15 (Invitrogen) supplemented with 10% FBS. MCF10A cells were cultured in DMEM/F12 supplemented with 5% horse serum (Atlanta Biologicals), 20 ng/ml EGF (Peprotech), 10 µg/ml insulin (Sigma), 0.5 µg/ml hydrocortisone (Sigma), and 100 ng/ ml cholera toxin (Sigma). HPDE-E6E7 cells were cultured in keratinocyte serum-free medium supplemented with bovine pituitary extract and EGF (Invitrogen). Constructs pEGFP-Rac1-WT, -DA, -DN, pEGFP-RhoA-WT, -V14, and -N19 [42] were gifts from Dr Alan Hall (MSKCC, USA). pQCX-IP-GFP and pQCXIP-GFP-KRasV12 were gifts from Ms Kirti Magudia from the lab of Dr Alan Hall. pQCXIP-mCherry was a gift from Ms Yuji Shi from the lab of Dr Xuejun Jiang (MSKCC, USA). pEGFP-p190A WT [43] was a gift from Dr Keith Burridge (UNC, USA). The RNA interference hairpin constructs for human Rac1 (Rac1iC3 and Rac1iC5) were gifts from Dr Joan Brugge.
Antibodies and chemical reagents
Virus production and infection
Viruses were produced as previously described [13] . Briefly, 1 × 10 6 293FT cells were plated into 6-well plates coated with poly-D-lysine. Transfection was performed with lenti-or retro-viral constructs together with packaging plasmids, and viruses were collected twice at 24-h intervals. To infect cells, 1 ml of viral supernatants mixed with 1 µl of polybrene from a 10 µg/ml stock was added to target cells for 12 h, followed by feeding with regular media. Cells were selected with puromycin (2 µg/ml) or G418 (200 µg/ml). Fluorescent protein-expressing cells were sorted by flow cytometry if needed.
Transfection and nucleofection
siGenome SMART pool siRNAs against human ROCKI and ROCKII were obtained from Dharmacon. For siRNA transfection, 1 × 10 5 MCF10A cells were transfected with 100 nM siRNA using Oligofectamine (Invitrogen). Cell analyses were performed 48 h post transfection. For nucleofection, 1 × 10 6 MCF10A cells were transfected with 6 µg of target plasmids by program T-24 using Nucleofector Solution V reagent (Lonza), and cell analyses were performed 12 h post nucleofection.
Quantification of cell-in-cell structures and winner/loser cell identity
To quantify cell-in-cell structures, cells were cultured in suspension for 6 h on Ultra-low Attachment plates (Corning) and then mounted onto glass slides by cytospin preparation and fixation in 10% trichloroacetic acid (TCA). Samples were immunostained with E-cadherin and β-catenin antibodies and analyzed by confocal microscopy as described [44] . Cell structures with more than half of cell body internalized were counted. For identity analysis of winners and losers, equal numbers of cells from two cell lines, stained with green or red CellTrackers (Invitrogen), were mixed together and cultured in suspension, and then plated into 0.4% soft agar or cytospun onto glass slides for analysis by confocal microscopy. To assess the effects of gene overexpression on cell identity, MCF-10A-mCherry-CAAX cells were nucleofected with constructs expressing GFP-tagged genes and cultured overnight, then placed into suspension for 3-4 h, and plated into 0.4% agar-containing medium for analysis by confocal microscopy. Structures formed between GFP-expressing and -non-expressing cells were analyzed.
Immunostaining and immunoblotting
For immunostaining [45] , cells were fixed with 4% PFA or 10% TCA, permeabilized with 0.2% Triton X-100/PBS for 5 min followed by blocking with 5% BSA for 1 h, and were incubated with primary antibodies in a humidified box overnight, followed by three 10-min washes with PBS. Secondary antibodies were applied for 1 h followed by three 10-min washes with PBS, and cells were counter-stained with DAPI and mounted with Prolong Gold antifade reagent (Invitrogen). For BrdU staining, additional procedures of denaturing with 2N HCl for 20 min and quenching with 0.1 M Na 2 B 4 O 7 for 2 min were performed before blocking. Immunoblotting was performed as previously described [46] .
Cell competition assay
MCF7 cells expressing GFP and VmCUB3 cells expressing mCherry were mixed in suspension for 7 h with or without npg www.cell-research.com | Cell Research Y27632, and then plated onto adherent cultures overnight in the absence of Y27632, followed by quantification of relative cell numbers by microscopy, or preparation of cell lysates for western blotting, the next morning. This procedure was repeated for the indicated number of cycles.
Xenograft tumor assay
Female 6-8-week-old SCID mice were ovariectomized and embedded with β-17 estradiol pellets 3 days before tumor implantation. Cells with 70%-80% confluence were trypsinized and counted, and equal numbers of MCF7 cells expressing GFP and VmCUB3 cells expressing mCherry were mixed before injection. Ten million total cells per tumor (mixture of MCF7 and VmCUB3 at 1:1 ratio) were injected subcutaneously, and Y27632 (10 µg/ kg) was administered on day 1 after cells were implanted and once daily thereafter. Tumors were collected on day 5 for sectioning. Tumor samples were fixed in 4% PFA for 2 h and then processed for paraffin embedding. Sections were deparaffinized as previously described [47] and retrieved in Tris-EDTA-Tween-20 (0.05%) solution in 100 o C water bath for 20 min before proceeding to TUNEL and immunostaining. Cell engulfments were identified by confocal microscopic examination of 10 µm tumor sections immunostained for GFP and E-cadherin. To verify that the cell engulfments identified in 10 m sections represent engulfment activity in 3-dimensions, engulfments were also examined in thick (30 µm) tumor sections through confocal z-planes. 91% of engulfments identified at the midplane of 30 µm sections contained at least 2/3 of one-cell-body internalized into another in 3-dimensions (Supplementary information, Figure S1D and S1E).
TUNEL assay
The ApopTag Plus Peroxidase In Situ Apoptosis Detection Kit (Millipore, S7101) was used to detect cell death in tumor sections according to the manufacturer's instructions. Briefly, antigen-retrieved sections were equilibrated and applied with TdT enzyme in a humidified chamber at 37 °C for 1 h. Reactions were stopped by incubating specimens in stop/wash buffer for 10 min before proceeding to standard immunostaining procedure as described above.
MPA
MPA was performed as previously described [48] , on intermediate entotic structures of MCF10A cells or single cells as indicated in suspension. For data analysis, the length of the deformation of cortex pulled into the micropipette (L p ) was normalized by the pipette radius (R p ), and L p /R p values were plotted as a function of applied pressure. These data were converted into apparent elastic moduli [49] (Table 1) .
Statistics P values were calculated by a two-tailed Student's t-test using Excel or GraphPad Prism 5 software. ANOVA with Fisher's least significant difference post hoc test and Wilcoxon sign-rank test were performed using Kaleidagraph software.
